FDA tells MPs: Little progress made in creating SCS opportunities outside London
FDA Assistant General Secretary Amy Leversidge has told MPs that “the dysfunctional nature of strategy making in the civil service” is partly responsible for a lack of progress in moving civil servants out of London.
“We discuss Places for Growth, but that doesn’t relate to what they’re doing with pay, that doesn’t relate to what they are doing with civil service numbers, but all of those things will have an interaction with each other,” she continued.
Leversidge demonstrated this with the government’s previous plans to cut 91,000 jobs. She said this meant the government had “already lost one of the levers you can pull”, as it limited the amount of new posts outside of London that were being advertised.
The Assistant General Secretary also told the Committee that for strategies like Places for Growth to work “ministers do need to be meaningfully working” outside of London as “the centre of gravity for every department is the minister, so if the minister is not based outside of London… the SCS posts will be drawn back”.
Again highlighting the dysfunctionality of government strategies for the civil service, Leversidge argued that you cannot “divorce” the reluctance of senior civil servants to work away from ministers “from ministerial attitudes that we’ve seen around hybrid working”. Leversidge said this had given “the impression that if you’re not directly seen by a minister then you’re not getting on with your job”, disincentivising relocation.
“The constant drumbeat we’ve had since 2016 of attacking civil servants”, continued Leversidge, alongside 10 years of falling real-terms wages, the plan to cut 91,000 jobs, and issues if ministerial behaviour “is having an incredibly damaging impact on morale and motivation”. As a result, the biggest concern is not that civil servants aren’t moving out of London, but they are “looking to leave the civil service”, as they can receive considerably better pay elsewhere.
Leversidge also discussed the momentous decision of FDA Fast Stream members to vote to take strike action. She warned that “chronic and longstanding issues with the pay structure” have actually left many Fast Stream members “terrified” of being placed in London due to the cost of housing, with many looking to leave the scheme altogether.
You can watch parts of Leversidge's appearance on the FDA Twitter page.
Latest News from
FDA achieves major breakthrough on Fast Stream pay17/08/2023 16:05:00
Following a long period of negotiations after the union’s successful ballot for industrial action earlier this year, the FDA has reached an agreement with the Cabinet Office on a significant new pay offer for the civil service Fast Stream.
“Ministers decide the shape and remit of the civil service”11/08/2023 15:10:00
The FDA has responded to a report from the Taxpayers’ Alliance that highlights the growth in the civil service headcount since 2016. FDA Assistant General Secretary Lucille Thirlby told GB News that “the case that the civil service is growing exponentially beyond any means, and by its own volition, is a complete nonsense. Ministers decide the shape and remit of the civil service”.
Watch out for signs of loan fee fraud as summer spending fuels financial pressure09/08/2023 15:05:00
With summer in full swing, the FCA launches its latest campaign to help consumers spot and avoid loan fee fraud.
FDA to build on improved pay offer by campaigning for reform of “broken” pay system14/06/2023 13:15:00
Last week, the FDA’s Executive Committee met to discuss the revised pay package announced by the Cabinet Office on 2 June. They agreed that it represents a significant improvement on the original pay framework for the civil service and addresses most of the factors that led to the dispute.
FDA to consider strike action in response to contemptuous announcement on civil service pay14/04/2023 16:05:00
The government has today published its approach to pay for 2023 in the civil service.
FDA calls on Prime Minister to give Independent Adviser power to make recommendations over Raab bullying findings10/02/2023 11:25:00
As reported by the Guardian, FDA General Secretary Dave Penman has written to the Prime Minister, urging him to consult his ethics adviser over bullying claims against the Deputy Prime Minister, Dominic Raab.
Williamson allegations shows Sunak must appoint ethics adviser11/11/2022 16:05:00
The FDA has responded to allegations against the former Minister without Portfolio Gavin Williamson, first published in the Guardian. The FDA highlighted the gulf that remains between Rishi Sunak’s intention to govern with integrity and the reality for government officials.
Unwillingness to address Vaz bullying at the time should 'weigh heavy' on Parliament, says FDA24/09/2021 09:25:00
Responding to the publication of the Independent Expert Panel report into the conduct of former MP Keith Vaz, FDA General Secretary Dave Penman paid tribute to the courage of Jenny McCullough, who brought the complaint and agreed to waive her right to confidentiality. Penman described how, by doing so, she had “not only shone a light on reprehensible conduct and behaviour of a senior member of Parliament, but also the inability of both Parliament and political parties to address these issues in the past".